Wael Yared
Chief Technology Officer & VP Corporate Developmen
bioinformatics
BioAnalytix
Japan
Biography
As Chief Technology Officer and Vice President of Corporate Development at BioAnalytix, Dr. Yared leads the development of the Company’s IT-driven workflows, advanced data analysis platforms and biologic informatics solutions. Previously, Dr. Yared led all product, software and platform development for PerkinElmer’s Life Sciences & Technology division and was founding director of the Company’s Center for Personalized Health Innovation. In this position, he oversaw R&D teams in the fields of imaging, microfluidics and automation for all hardware, software and reagent development activities across multiple sites in the US and Europe. Prior to this role, Dr. Yared was Chief Technology Officer for VisEn Medical, acquired by Perkin Elmer in August 2010, where he led the development of quantitative fluorescence molecular tomography systems and molecular agent portfolios. Dr. Yared holds a PhD from the Massachusetts Institute of Technology, and is a named inventor and author on a number of patents and publications.
Research Interest
biologic informatics
